Choosing a Cloning Vector
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cloning of Gene Coding Glyceraldehyde-3-Phosphate Dehydrogenase Using Puc18 Vector
Available online a t www.pelagiaresearchlibrary.com Pelagia Research Library European Journal of Experimental Biology, 2015, 5(3):52-57 ISSN: 2248 –9215 CODEN (USA): EJEBAU Cloning of gene coding glyceraldehyde-3-phosphate dehydrogenase using puc18 vector Manoj Kumar Dooda, Akhilesh Kushwaha *, Aquib Hasan and Manish Kushwaha Institute of Transgene Life Sciences, Lucknow (U.P), India _____________________________________________________________________________________________ ABSTRACT The term recombinant DNA technology, DNA cloning, molecular cloning, or gene cloning all refers to the same process. Gene cloning is a set of experimental methods in molecular biology and useful in many areas of research and for biomedical applications. It is the production of exact copies (clones) of a particular gene or DNA sequence using genetic engineering techniques. cDNA is synthesized by using template RNA isolated from blood sample (human). GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) is one of the most commonly used housekeeping genes used in comparisons of gene expression data. Amplify the gene (GAPDH) using primer forward and reverse with the sequence of 5’-TGATGACATCAAGAAGGTGGTGAA-3’ and 5’-TCCTTGGAGGCCATGTGGGCCAT- 3’.pUC18 high copy cloning vector for replication in E. coli, suitable for “blue-white screening” technique and cleaved with the help of SmaI restriction enzyme. Modern cloning vectors include selectable markers (most frequently antibiotic resistant marker) that allow only cells in which the vector but necessarily the insert has been transfected to grow. Additionally the cloning vectors may contain color selection markers which provide blue/white screening (i.e. alpha complementation) on X- Gal and IPTG containing medium. Keywords: RNA isolation; TRIzol method; Gene cloning; Blue/white screening; Agarose gel electrophoresis. -
Stability of Cole1-Like and Pbr322-Like Plasmids in Escherichia Coli
Molecular Microbiology (1989) 3(12). 1745-1752 Stability of ColE1-like and pBR322-like plasmids in Escherichia coli J. Aya la-San martin and M. C. G6mez-Eichelmann* piasmid-specifio DNA sequence to a cellular partition Departamento de Biologia Molecular, Instituto de system (Miki ef al., 1980; Gustafsson et al., 1983); (iii) Investigaciones Biomedicas, Universidad Nacional site-specific recombination of multimers to provide an Autonoma de Mexico. Apto Postal 70-228, 04510 adequate number of units for partitioning (Austin et al.. Mexico. D.F. Mexico. 1981; Sherratt et aL, 1986); (iv) post-segregational killing. which prevents the appearance of plasmid-free cells in a growing culture (Jaffe et al.. 1985; Gerdes etal., 1986); and Summary (iv) temporal inhibition of cell division if the plasmid The average copy number, the level of ampicillin replication process does not provide a sufficient number resistance conferred by one plasmid, and the degree of plasmid copies per cell cycle (Ogura and Hiraga, 1983a; of plasmid multimerization were determined for Miki ef a/., 1984). Different plasmids display distinct several ColE1-like and pBR322-like plasmids. From strategies to ensure an accurate partition and therefore the results obtained, the variance of the units of stability. The low oopy-number plasmids, F. R1 and partition corresponding to each plasmid studied was prophage P1, and the intermediate copy-number plasmid, calculated. Experimentally determined plasmid stabi- pSCIOI, in addition to other strategies to ensure their lity was compared with that calculated using the stability, code for functions involved in active partition variance of the units of partition and the ratio between (Meacock and Cohen, 1980; Nordstrom ef al. -
GFP Plasmid) 35X
Název: Biotechnology and Fluorescent protein Školitel: Ana Maria Jimenez Jimenez, Iva Blažková Datum: 19.7.2013 Reg.č.projektu: CZ.1.07/2.3.00/20.0148 Název projektu: Mezinárodní spolupráce v oblasti "in vivo" zobrazovacích technik INTRODUCTION GFP - Green fluorescent protein A protein composed of 238 amino acid residues (26.9 kDa) exhibits bright green fluorescence when exposed to light in the blue to ultraviolet range GFP was isolated from the jellyfish Aequorea victoria. In cell and molecular biology, the GFP gene is frequently used as a reporter of expression The GFP gene has been introduced and expressed in many bacteria, yeast and other fungi, fish, plant and mammalian cells. Green fluorescent protein (GFP) Nobel prize in Chemistry (2008): for the discovery and development of the green fluorescent protein, GFP Osamu Shimomura Martin Chalfie Roger Y. Tsien Now GFP is found in laboratories all over the world where it is used in every conceivable plant and animal GFP Types Fluorescent proteins enable the creation of highly specific biosensors to monitor a wide range of intracellular phenomena. Mutagenesis of A. victoria GFP has resulted in fluorescent proteins that range in color from blue to yellow Transluminator Fluoresence spectrophotometry Fluorescence In-vivo Xtreme Detection Fluorescence microscopy In-vivo Xtreme cm Polyacrylamide gel In-vivo Xtreme 1/16 1/8 1/4 1/2 1 10000 y = 9003x + 732,46 9000 R² = 0,9984 Max-Backgroumd 8000 7000 Rostoucí koncentrace Mean-Background 6000 5000 4000 3000 y = 5748,2x + 490,64 R² = 0,9995 2000 Fluorescence intensity [a.u.] 1000 0 0 0,2 0,4 0,6 0,8 1 1,2 concentration [µg/ml] In-vivo Xtreme GFP encapsulated GFP in liposome GFP water in liposome Max.int: 8800 a. -
Molecular Biology and Applied Genetics
MOLECULAR BIOLOGY AND APPLIED GENETICS FOR Medical Laboratory Technology Students Upgraded Lecture Note Series Mohammed Awole Adem Jimma University MOLECULAR BIOLOGY AND APPLIED GENETICS For Medical Laboratory Technician Students Lecture Note Series Mohammed Awole Adem Upgraded - 2006 In collaboration with The Carter Center (EPHTI) and The Federal Democratic Republic of Ethiopia Ministry of Education and Ministry of Health Jimma University PREFACE The problem faced today in the learning and teaching of Applied Genetics and Molecular Biology for laboratory technologists in universities, colleges andhealth institutions primarily from the unavailability of textbooks that focus on the needs of Ethiopian students. This lecture note has been prepared with the primary aim of alleviating the problems encountered in the teaching of Medical Applied Genetics and Molecular Biology course and in minimizing discrepancies prevailing among the different teaching and training health institutions. It can also be used in teaching any introductory course on medical Applied Genetics and Molecular Biology and as a reference material. This lecture note is specifically designed for medical laboratory technologists, and includes only those areas of molecular cell biology and Applied Genetics relevant to degree-level understanding of modern laboratory technology. Since genetics is prerequisite course to molecular biology, the lecture note starts with Genetics i followed by Molecular Biology. It provides students with molecular background to enable them to understand and critically analyze recent advances in laboratory sciences. Finally, it contains a glossary, which summarizes important terminologies used in the text. Each chapter begins by specific learning objectives and at the end of each chapter review questions are also included. -
Cosmid Vectors for Streptomycetes Genomic DNA Cloning
Europaisches Patentamt 19 European Patent Office Office europeen des brevets (n) Publication number : 0 620 280 A1 EUROPEAN PATENT APPLICATION (21) Application number : 94302414.1 © int. ci.5: C12N 15/70, C12N 15/76, C12N 1/21, //(C12N1/21, (22) Date of filing : 05.04.94 C12R1:19, 1:465, 1:55) (30) Priority : 16.04.93 US 48719 (72) Inventor : Denoya, Claudio D. 80 Spyglass Circle Groton, Connecticut 06340 (US) @ Date of publication of application : 19.10.94 Bulletin 94/42 (74) Representative : Moore, James William, Dr. Pfizer Limited @ Designated Contracting States : Ramsgate Road AT BE CH DE DK ES FR GB GR IE IT LI LU NL Sandwich Kent CT13 9NJ (GB) PT SE @ Applicant : PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 (US) (54) Cosmid vectors for streptomycetes genomic DNA cloning. (57) Novel cosmid cloning vectors are disclosed. Such vectors facilitate many steps involved in cloning chromosomal DNA restriction fragments from streptomycetes. The cosmids have Adenine and Thymine-rich recognition sequences for several restriction enzymes flanking cloning sites. Also disclosed are host cells containing the novel cosmid cloning vectors. o 00 CM o CM CO LU Jouve, 18, rue Saint-Denis, 75001 PARIS EP 0 620 280 A1 Background of the Invention The present invention relates to a set of novel cosmid cloning vectors that facilitate gene cloning in a wide variety of streptomycetes, including the avermectin-producing microorganism Streptomyces avermitilis. 5 The application of recombinant DNA techniques in antibiotic-producing microorganisms constitutes an in- creasingly important area of biotechnological research. Streptomycetes are gram- positive microorganisms that are well known for their ability to produce a variety of commercially useful therapeutic substances. -
Cdna Libraries and Expression Libraries
Solutions for Practice Problems for Recombinant DNA, Session 4: cDNA Libraries and Expression Libraries Question 1 In a hypothetical scenario you wake up one morning to your roommate exclaiming about her sudden hair growth. She has been supplementing her diet with a strange new fungus purchased at the local farmer’s market. You take samples of the fungus to your lab and you find that this fungus does indeed make a protein (the harE protein) that stimulates hair growth. You construct a fungal genomic DNA library in E. Coli with the hope of cloning the harE gene. If you succeed you will be a billionaire! You obtain DNA from the fungus, digest it with a restriction enzyme, and clone it into a vector. a) What features must be present on your plasmid that will allow you to use this as a cloning vector to make fungal genomic DNA library. Your vector would certainly need to have a unique restriction enzyme site, a selectable marker such as the ampicillin resistance gene, and a bacterial origin of replication. Other features may be required depending upon how you plan to use this library. b) You clone your digested genomic DNA into this vector. The E. coli (bacteria) cells that you will transform to create your library will have what phenotype prior to transformation? Prior to transformation, the E. coli cells that you will transform will be sensitive to antibiotic. This allows you to select for cells that obtained a plasmid. c) How do you distinguish bacterial cells that carry a vector from those that do not? Cells that obtained a vector will have obtained the selectable marker (one example is the ampicillin resistance gene). -
Gene Cloningcloningcloning
GeneGeneGene CloningCloningCloning 20042004 SeungwookSeungwookKim Kim Chem.Chem. && Bio.Bio. Eng.Eng. Reference z T.A. Brown, Gene Cloning, Chapman and Hall z S.B. Primrose, Molecular Biotechnology, Blackwell 1 Why Gene Cloning is Important? z A century ago, Gregor Mendel : { Basic assumption (each heritable property of an organism) is controlled by a factor (gene). z In 1900, Mandel's law Æ the birth of genetics. z what these genes are and exactly how they work The Early Development of Genetics z In 1903, Sutton, W { Proposed that genes reside on chromosomes 2 z In 1910, Morgan, TH { Experimental backing on that --> development of the techniques for gene mapping (To establish the structure or structural details or location) { By 1922, a comprehensive analysis of the relative positions of over 2000 genes on the four chromosomes of the fruit fly. (Drosophilia melanogaster) z In 1944, Avery, MacLeod and McCarty z In 1952, Hershey and Chase { Experimental results were shown that DNA is the genetic material. { Conventional idea : genes were made of protein z In 1952-1966, Delbruck, Chargaff, Crick and Monod { The structure of DNA was elucidated. { The genetic code was cracked. { The process of transcription and translation were described. 3 The Advent of Gene Cloning z In the late 1960's ; The experimental techniques were not sophisticated. z In 1971 ~ 1973 ; A new experimental techniques were developed. { Recombinant DNA technology or Genetic engineering based on the process of gene cloning { This led to rapid and efficient DNA sequencing techniques that enabled the structures of individual genes to be determined. z In the 1990s ; started with massive genome sequencing projects including the human project. -
10. E. Coli Cloning Vector Pbr322
10. E. coli cloning vector pBR322 Important questions based on it: A. (a) Name the organism in which the vector shown is inserted to get the copies of the desired gene. (b) Mention the area labelled in the vector responsible for controlling the copy number of the inserted gene. (c) Name and explain the role of a selectable marker in the vector shown. (AI 2010) B. (a) Identify the selectable markers in the diagram of E. coli vector shown below. (b) How is the coding sequence of -galactosidase considered a better marker than the ones identified by you in the diagram? Explain. (Delhi 2009) A. Explain the importance of (a) ori, (b) ampR and (c) rop in the E. coli vector shown below. (AI 2008) B. Draw pBR322 cloning vector. Label ‘ori’, ‘rop’ and any one antibiotic resistance site on it and state their functions. (AI 2015C) C. Draw a schematic diagram of the E. coli cloning vector pBR322 and mark the following in it: (a) ori (b) rop (c) ampicillin resistance gene (d) tetracycline resistance gene (e) restriction site BamHI (f) restriction site EcoR I (AI 2014C) D. Draw a schematic sketch of pBR322 plasmid and label the following in it: (a) Any two restriction sites. (b) Ori and rop genes. (c) An antibiotic resistant gene. (Delhi 2012) E. Identify A, B, C and D in the given diagram. (a) A-ori, B-ampR, C-tetR, D-HindIII (b) A-HindIII, B-tetR, C-ampR, D-ori (c) A-ampR, B-tetR, C-HindIII, D-ori (d) A-tetR, B-HindIII, C-ori, D-ampR (COMEDK) F. -
Pspark® DNA Cloning System Manual for Cat
pSpark® DNA cloning system Manual for cat. nº : C0001 (pSpark® I) C0002 (pSpark® II) C0003 (pSpark® III) C0004 (pSpark® IV) C0005 (pSpark® V) C0006 (pSpark® Done) Upon Receipt Store Kits at -20°C PRODUCT MANUAL Version 3.0 Last updated: December 2012 www.canvaxbiotech.com TABLE OF CONTENTS TABLE OF CONTENTS ii MATERIALS PROVIDED, KIT STORAGE AND EXPIRATION DATE iii 1. INTRODUCTION 1 1.1 Principle and advantages 1 1.2 The family of pSpark® DNA cloning vectors 2 1.3 pSpark® DNA cloning vector maps 3 1.4 Specialized applications of the pSpark® DNA cloning systems 4 1.5 Additional materials required (but NOT supplied with kits unless otherwise stated)4 2. DETAILED PROTOCOL 5 2.1 Experimental outline 5 2.2 PCR 6 2.2.1 PCR Primers design 6 2.2.2 PCR Amplification 6 2.3 Ligation 8 2.3.1 Amount of insert needed for ligation into pSpark® DNA cloning systems. 8 2.3.2 Protocol for ligation using the pSpark® DNA cloning systems 10 2.3.3 Tips for cloning of long or problematic PCR products. 11 2.4 Transformation 12 2.4.1 General considerations about transformation into E coli 12 2.4.2 Standard protocol for transformation 13 2.4.3 Fast transformation protocol (Recommended alternative) 14 2.4.4 Transformation by electroporation protocol 16 2.5 Selection of recombinants 17 2.5.1 Expected results 17 2.6 Analysis of transformants 20 2.6.1 PCR directly from bacterial colonies (Colony PCR protocol) 20 2.6.2 Isolation of plasmid DNA 21 2.6.3 Sequencing 22 2.6.4 Long term storage of sequence-verified clones 22 3. -
Large-Insert BAC/YAC Libraries for Selective Re-Isolation of Genomic Regions by Homologous Recombination in Yeast
doi:10.1006/geno.2001.6616, available online at http://www.idealibrary.com on IDEAL Article Large-Insert BAC/YAC Libraries for Selective Re-isolation of Genomic Regions by Homologous Recombination in Yeast Changjiang Zeng,1,5 Natalay Kouprina,2 Baoli Zhu,1,5 Al Cairo,1 Maarten Hoek,3 George Cross,3 Kazutoyo Osoegawa,1,5 Vladimir Larionov,2 and Pieter de Jong1,5,* 1Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA 2Laboratory of Biosystems and Cancer, National Cancer Institute, Bethesda, Maryland 20892, USA 3Laboratory of Molecular Parasitology, Rockefeller University, New York, New York 10021, USA 4Present address: Exelixis, South San Francisco, California 94080, USA 5Present address: Children’s Hospital Oakland, BACPAC Resources, 747-52nd Street, Oakland, California 94609, USA *To whom correspondence and reprint requests should be addressed. Fax: (510) 749-4266. E-mail: [email protected]. We constructed representative large-insert bacterial artificial chromosome (BAC) libraries of two human pathogens (Trypanosoma brucei and Giardia lamblia) using a new hybrid vector, pTARBAC1, containing a yeast artificial chromosome (YAC) cassette (a yeast selectable marker and a centromere). The cassette allows transferring of BACs into yeast for their fur- ther modification. Furthermore, the new hybrid vector provides the opportunity to re-isolate each DNA insert without construction of a new library of random clones. Digestion of a BAC DNA by an endonuclease that has no recognition site in the vector, but which deletes most of the internal insert sequence and leaves the unique flanking sequences, converts a BAC into a TAR vector, thus allowing direct gene isolation. -
Pcor: a New Design of Plasmid Vectors for Nonviral Gene Therapy
Gene Therapy (1999) 6, 1482–1488 1999 Stockton Press All rights reserved 0969-7128/99 $12.00 http://www.stockton-press.co.uk/gt BRIEF COMMUNICATION pCOR: a new design of plasmid vectors for nonviral gene therapy F Soubrier, B Cameron, B Manse, S Somarriba, C Dubertret, G Jaslin, G Jung, C Le Caer, D Dang, JM Mouvault, D Scherman, JF Mayaux and J Crouzet Rhoˆne-Poulenc Rorer, Centre de Recherche de Vitry Alfortville, 13 Quai J Guesde, 94403 Vitry-sur-Seine, France A totally redesigned host/vector system with improved initiator protein, protein, encoded by the pir gene limiting properties in terms of safety has been developed. The its host range to bacterial strains that produce this trans- pCOR plasmids are narrow-host range plasmid vectors for acting protein; (2) the plasmid’s selectable marker is not an nonviral gene therapy. These plasmids contain a con- antibiotic resistance gene but a gene encoding a bacterial ditional origin of replication and must be propagated in a suppressor tRNA. Optimized E. coli hosts supporting specifically engineered E. coli host strain, greatly reducing pCOR replication and selection were constructed. High the potential for propagation in the environment or in yields of supercoiled pCOR monomers were obtained (100 treated patients. The pCOR backbone has several features mg/l) through fed-batch fermentation. pCOR vectors carry- that increase safety in terms of dissemination and selec- ing the luciferase reporter gene gave high levels of lucifer- tion: (1) the origin of replication requires a plasmid-specific ase activity when injected into murine skeletal muscle. Keywords: gene therapy; plasmid DNA; conditional replication; selection marker; multimer resolution Two different types of DNA vehicles, based criteria.4 These high copy number plasmids carry a mini- on recombinant viruses and bacterial DNA plasmids, are mal amount of bacterial sequences, a conditional origin used in gene therapy. -
Molecular Cloning Plasmid-Based Cloning Vectors
Page: 1 Molecular Cloning A glaring problem in most areas of biochemical research is obtaining sufficient amounts of the substance of interest. For example, a 10 L culture of E. coli grown to its maximum titer will only contain about 7 mg of DNA polymerase I, and many other proteins in much lesser amounts. Furthermore, only rarely can as much as half of any protein originally present in an organism be recovered in pure form. Eucaryotic proteins are even more difficult to obtain because tissue samples are usually only available in small quantities. With regards to the amount of DNA present, the 10 L E. coli culture would contain about 0.1mg of any 1000 bp length chromosomal DNA but its purification in the presence of the rest of the chromosomal DNA would be a very difficult task. These difficulties have been greatly reduced through the development of molecular cloning techniques. These methods, which are also referred to as genetic engineering and recombinant DNA technology, deserve much of the credit for the enormous progress in biochemistry and the dramatic rise of the biotechnology industry. The main idea of molecular cloning is to insert a DNA segment of interest into an autonomously replicating DNA molecule, a so-called cloning vector, so that the DNA segment is replicated with the vector. Cloning such a chimeric vector in a suitable host organism such as E. coli or yeast results in the production of large amounts of the inserted DNA segment. If a cloned gene is flanked by the properly positioned control sequences for RNA and protein synthesis, the host may also produce large quantities of the mRNA and protein specified by that gene.